| scholarly article | Q13442814 |
| P50 | author | Leon Schurgers | Q60061818 |
| P2093 | author name string | Etienne Benoit | |
| Virginie Lattard | |||
| Arnaud Michaux | |||
| Benjamin Matagrin | |||
| Jean-Valéry Debaux | |||
| P2860 | cites work | VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection) | Q82891113 |
| Vitamin K intake and status are low in hemodialysis patients | Q84251369 | ||
| Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients | Q84579705 | ||
| Biochemical characterization of spontaneous mutants of rat VKORC1 involved in the resistance to antivitamin K anticoagulants | Q84928733 | ||
| Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation | Q87105739 | ||
| VKORC1 mutations detected in patients resistant to vitamin K antagonists are not all associated with a resistant VKOR activity | Q87413629 | ||
| VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy | Q28114887 | ||
| Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2 | Q28242581 | ||
| The vitamin K cycle | Q28274345 | ||
| Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein | Q28304798 | ||
| Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype | Q34033497 | ||
| Association of warfarin use with valvular and vascular calcification: a review. | Q34162996 | ||
| Oral anticoagulant treatment: friend or foe in cardiovascular disease? | Q34334786 | ||
| Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. | Q34543641 | ||
| Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. | Q34573161 | ||
| Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans | Q34618352 | ||
| Consequences of the Y139F Vkorc1 mutation on resistance to AVKs: in-vivo investigation in a 7th generation of congenic Y139F strain of rats | Q35008925 | ||
| Vascular calcification: Mechanisms of vascular smooth muscle cell calcification | Q35553833 | ||
| Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - rationale and perspectives | Q36679917 | ||
| Vitamin K nutrition, metabolism, and requirements: current concepts and future research | Q36828726 | ||
| A cardiovascular phenotype in warfarin-resistant Vkorc1 mutant rats | Q37088955 | ||
| Evaluation of warfarin resistance using transcription activator-like effector nucleases-mediated vitamin K epoxide reductase knockout HEK293 cells | Q37100171 | ||
| Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging? | Q37582670 | ||
| Role of vitamin K-dependent proteins in the arterial vessel wall | Q37895509 | ||
| Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization | Q38078666 | ||
| New insights into the catalytic mechanism of vitamin K epoxide reductase (VKORC1) - The catalytic properties of the major mutations of rVKORC1 explain the biological cost associated to mutations. | Q41261871 | ||
| Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system. | Q41652760 | ||
| VKORC1 pharmacogenomics summary | Q41968877 | ||
| Origin of the gender differences of the natural resistance to antivitamin K anticoagulants in rats | Q42488814 | ||
| Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves | Q42539622 | ||
| Does prolonged warfarin exposure potentiate coronary calcification in humans? Results of the warfarin and coronary calcification study | Q43257060 | ||
| Warfarin use and the risk of valvular calcification | Q43269077 | ||
| Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam Study | Q44304946 | ||
| Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment | Q44460442 | ||
| Sequence variation in vitamin K epoxide reductase gene is associated with survival and progressive coronary calcification in chronic kidney disease | Q44581119 | ||
| Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease | Q45370236 | ||
| Relation of circulating Matrix Gla-Protein and anticoagulation status in patients with aortic valve calcification. | Q50357086 | ||
| Susceptiveness of Vitamin K epOxide Reductase Complex Subunit 1 Gene Polymorphism in Essential Hypertension. | Q51102753 | ||
| Warfarin and vitamin K compete for binding to Phe55 in human VKOR. | Q51273552 | ||
| VKORC1 gene (vitamin K epoxide reductase) polymorphisms are associated with cardiovascular disease in chronic kidney disease patients on hemodialysis. | Q51382670 | ||
| Establishing a rat model for the study of vitamin K deficiency. | Q51723075 | ||
| Association of VKORC1 -1639 G>A polymorphism with carotid intima-media thickness in type 2 diabetes mellitus. | Q54358882 | ||
| Linkages between Genes for Coat Colour and Resistance to Warfarin in Rattus norvegicus | Q54685045 | ||
| Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats | Q56905413 | ||
| Newly developed model for vitamin K deficiency in germfree mice | Q68413986 | ||
| Warfarin metabolism and vitamin K requirement in the warfarin-resistant rat | Q71224892 | ||
| Effect of feeding vitamin K-deficient diets to female rats | Q79073442 | ||
| Vitamin K deficiency in rats induced by the feeding of irradiated beef | Q79325593 | ||
| Estimation of warfarin maintenance dose based on VKORC1 (-1639 G>A) and CYP2C9 genotypes | Q80352091 | ||
| Age and dietary form of vitamin K affect menaquinone-4 concentrations in male Fischer 344 rats | Q80738286 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 13733 | |
| P577 | publication date | 2018-09-13 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Missense mutation of VKORC1 leads to medial arterial calcification in rats | |
| P478 | volume | 8 |
Search more.